These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 33359838)

  • 1. Endocrine disrupting chemicals and metabolic disorders in the liver: What if we also looked at the female side?
    Le Magueresse-Battistoni B
    Chemosphere; 2021 Apr; 268():129212. PubMed ID: 33359838
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adipose Tissue and Endocrine-Disrupting Chemicals: Does Sex Matter?
    Le Magueresse-Battistoni B
    Int J Environ Res Public Health; 2020 Dec; 17(24):. PubMed ID: 33333918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut Microbiota, Endocrine-Disrupting Chemicals, and the Diabetes Epidemic.
    Velmurugan G; Ramprasath T; Gilles M; Swaminathan K; Ramasamy S
    Trends Endocrinol Metab; 2017 Aug; 28(8):612-625. PubMed ID: 28571659
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic effects of nuclear receptor activation in vivo after 28-day oral exposure to three endocrine-disrupting chemicals.
    Attema B; Kummu O; Pitkänen S; Weisell J; Vuorio T; Pennanen E; Vorimo M; Rysä J; Kersten S; Levonen AL; Hakkola J
    Arch Toxicol; 2024 Mar; 98(3):911-928. PubMed ID: 38182912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dietary exposure to endocrine disruptors in gut microbiota: A systematic review.
    Calero-Medina L; Jimenez-Casquet MJ; Heras-Gonzalez L; Conde-Pipo J; Lopez-Moro A; Olea-Serrano F; Mariscal-Arcas M
    Sci Total Environ; 2023 Aug; 886():163991. PubMed ID: 37169193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolism disrupting chemicals and metabolic disorders.
    Heindel JJ; Blumberg B; Cave M; Machtinger R; Mantovani A; Mendez MA; Nadal A; Palanza P; Panzica G; Sargis R; Vandenberg LN; Vom Saal F
    Reprod Toxicol; 2017 Mar; 68():3-33. PubMed ID: 27760374
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Persistent Endocrine-Disrupting Chemicals and Fatty Liver Disease.
    Deierlein AL; Rock S; Park S
    Curr Environ Health Rep; 2017 Dec; 4(4):439-449. PubMed ID: 28980219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypothetical roadmap towards endometriosis: prenatal endocrine-disrupting chemical pollutant exposure, anogenital distance, gut-genital microbiota and subclinical infections.
    García-Peñarrubia P; Ruiz-Alcaraz AJ; Martínez-Esparza M; Marín P; Machado-Linde F
    Hum Reprod Update; 2020 Feb; 26(2):214-246. PubMed ID: 32108227
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine Disruptors in Food: Impact on Gut Microbiota and Metabolic Diseases.
    Gálvez-Ontiveros Y; Páez S; Monteagudo C; Rivas A
    Nutrients; 2020 Apr; 12(4):. PubMed ID: 32326280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatic consequences of a mixture of endocrine-disrupting chemicals in male mice.
    Rahman MS; Pang WK; Amjad S; Ryu DY; Adegoke EO; Park YJ; Pang MG
    J Hazard Mater; 2022 Aug; 436():129236. PubMed ID: 35739755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of exposure to endocrine disrupting chemicals in obesity and neurodevelopment: The genetic and microbiota link.
    Ramírez V; González-Palacios P; Baca MA; González-Domenech PJ; Fernández-Cabezas M; Álvarez-Cubero MJ; Rodrigo L; Rivas A
    Sci Total Environ; 2022 Dec; 852():158219. PubMed ID: 36007653
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endocrine disrupting chemicals (EDCs) and the neuroendocrine system: Beyond estrogen, androgen, and thyroid.
    Patisaul HB
    Adv Pharmacol; 2021; 92():101-150. PubMed ID: 34452685
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mate choice, sexual selection, and endocrine-disrupting chemicals.
    Gore AC; Holley AM; Crews D
    Horm Behav; 2018 May; 101():3-12. PubMed ID: 28888817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Exposure to environmental endocrine disrupting compounds and men's health.
    Meeker JD
    Maturitas; 2010 Jul; 66(3):236-41. PubMed ID: 20347536
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of early exposure to phthalates and bisphenols on cardiometabolic outcomes in pregnancy and childhood.
    Philips EM; Jaddoe VWV; Trasande L
    Reprod Toxicol; 2017 Mar; 68():105-118. PubMed ID: 27596818
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Interplay between Endocrine-Disrupting Chemicals and the Epigenome towards Metabolic Dysfunction-Associated Steatotic Liver Disease: A Comprehensive Review.
    Mentsiou Nikolaou E; Kalafati IP; Dedoussis GV
    Nutrients; 2024 Apr; 16(8):. PubMed ID: 38674815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DEDuCT 2.0: An updated knowledgebase and an exploration of the current regulations and guidelines from the perspective of endocrine disrupting chemicals.
    Karthikeyan BS; Ravichandran J; Aparna SR; Samal A
    Chemosphere; 2021 Mar; 267():128898. PubMed ID: 33190914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human exposure to endocrine disrupting compounds: Their role in reproductive systems, metabolic syndrome and breast cancer. A review.
    Giulivo M; Lopez de Alda M; Capri E; Barceló D
    Environ Res; 2016 Nov; 151():251-264. PubMed ID: 27504873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Environmental non-persistent endocrine-disrupting chemicals exposure and reproductive hormones levels in adult men.
    Dziewirska E; Hanke W; Jurewicz J
    Int J Occup Med Environ Health; 2018 Oct; 31(5):551-573. PubMed ID: 30228382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The emerging role of endocrine disruptors in pathogenesis of insulin resistance: a concept implicating nonalcoholic fatty liver disease.
    Polyzos SA; Kountouras J; Deretzi G; Zavos C; Mantzoros CS
    Curr Mol Med; 2012 Jan; 12(1):68-82. PubMed ID: 22082482
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.